Zobrazeno 1 - 3
of 3
pro vyhledávání: '"J. J. Lambea Sorrosal"'
Autor:
Antonio Rueda, B. Cirauqui Cirauqui, A. Carral Maseda, J. J. Lambea Sorrosal, J.J. Cruz Hernandez, V. Arrazubi Arrula, L. C. Iglesias Docampo, Y. Escobar, M. Pastor Borgoñón, N. Baste Rotllan
Publikováno v:
Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madrid
Clinical & Translational Oncology
Zaguán. Repositorio Digital de la Universidad de Zaragoza
instname
Consejería de Sanidad de la Comunidad de Madrid
Clinical & Translational Oncology
Zaguán. Repositorio Digital de la Universidad de Zaragoza
instname
Head and neck cancer (HNC) is defined as malignant tumours located in the upper aerodigestive tract and represents 5% of oncologic cases in adults in Spain. More than 90% of these tumours have squamous histology. In an effort to incorporate evidence
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c789eb5c1a24b3c6ce509594a6e4504c
https://hdl.handle.net/20.500.12530/29659
https://hdl.handle.net/20.500.12530/29659
Autor:
Martínez-Trufero J; Medical Oncology Department, University Hospital Miguel Servet, Av. Isabel la Católica 1-3, 50009, Zaragoza, Spain. jmtrufero@seom.org., Lozano Borbalas A; Radiation Oncology Service, Institut Català D'Oncologia (ICO) Hospitalet, Barcelona, Spain., Pajares Bernad I; Medical Oncology Department, University Hospital Miguel Servet, Av. Isabel la Católica 1-3, 50009, Zaragoza, Spain., Taberna Sanz M; Medical Oncology Service, Institut Català D'Oncologia (ICO) Hospitalet, Barcelona, Spain., Ortega Izquierdo E; Medical Oncology Department, University Hospital Miguel Servet, Av. Isabel la Católica 1-3, 50009, Zaragoza, Spain., Cirauqui Cirauqui B; Medical Oncology Service, Institut Català D'Oncologia (ICO) Badalona, Barcelona, Spain., Rubió-Casadevall J; Medical Oncology Service, Institut Català D'Oncologia (ICO) Girona, University Hospital Josep Trueta, Girona, Spain., Plana Serrahima M; Medical Oncology Service, Institut Català D'Oncologia (ICO) Hospitalet, Barcelona, Spain., Ponce Ortega JM; Radiation Oncology Service, University Hospital Miguel Servet, Zaragoza, Spain., Planas Toledano I; Radiation Oncology Service, Institut Català D'Oncologia (ICO) Badalona, Barcelona, Spain., Caballero J; Medical Oncology Service, University and Polytechnic Hospital La Fe, Valencia, Spain., Marruecos Querol J; Radiation Oncology Service, Institut Català D'Oncologia (ICO) Girona, University Hospital Josep Trueta, Girona, Spain., Iglesias Docampo L; Medical Oncology Service, University Hospital 12 de Octubre, Madrid, Spain., Lambea Sorrosal J; Medical Oncology Service, University Hospital Lozano Blesa, Zaragoza, Spain., Adansa JC; Biomedical Research Institute of Salamanca, Salamanca, Spain., Mesía Nin R; Medical Oncology Service, Institut Català D'Oncologia (ICO) Hospitalet, Barcelona, Spain.
Publikováno v:
Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico [Clin Transl Oncol] 2021 Aug; Vol. 23 (8), pp. 1666-1677. Date of Electronic Publication: 2021 Apr 19.
Autor:
Hitt R; Medical Oncology Department, Hospital Universitario Severo Ochoa, Avda. de Orellana, s/n, 28911, Leganés (Madrid), Spain. rhitt@telefonica.net., Iglesias L; Medical Oncology Department, Hospital Universitario, 12 de Octubre, Madrid, Spain., López-Pousa A; Medical Oncology Department, Hospital de la Santa Creu i Sant Pau, Calalunya, Spain., Berrocal-Jaime A; Medical Oncology Department, Consorci Hospital General Universitari de Valencia, Valencia, Spain., Grau JJ; Medical Oncology Department, Hospital Clinic de Barcelona, Catalunya, Spain., García-Girón C; Medical Oncology Department, Hospital Universitario de Burgos, Castilla y León, Spain., Martínez-Trufero J; Medical Oncology Department, Hospital Universitario Miguel Servet, Aragón, Spain., Guix M; Medical Oncology Department, Hospital del Mar, Barcelona, Spain.; Cancer Research Program (CIBERONC), Institut Mar d Investigacions Mèdiques (IMM), Barcelona, Spain., Lambea-Sorrosal J; Medical Oncology Department, Hospital Clínico Lozano Blesa, Zaragoza, Spain., Del Barco-Morillo E; Medical Oncology Department, Hospital Universitario de Salamanca, Castilla y León, Spain.; Institute for Biomedical Research of Salamanca (IBSAL), Castilla y León, Spain., León-Vintró X; ENT Department, Hospital de la Santa Creu i Sant Pau, Catalunya, Spain., Cunquero-Tomas AJ; Medical Oncology Department, Consorci Hospital General Universitari de Valencia, Valencia, Spain., Baste N; Medical Oncology Department, Hospital Clinic de Barcelona, Catalunya, Spain., Ocaña A; Medical Oncology Department, Hospital Universitario de Salamanca, Castilla y León, Spain.; Institute for Biomedical Research of Salamanca (IBSAL), Castilla y León, Spain., Cruz-Hernández JJ; Medical Oncology Department, Hospital Universitario de Salamanca, Castilla y León, Spain.; Institute for Biomedical Research of Salamanca (IBSAL), Castilla y León, Spain.
Publikováno v:
Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico [Clin Transl Oncol] 2021 Apr; Vol. 23 (4), pp. 764-772. Date of Electronic Publication: 2020 Aug 14.